{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:31:11Z","timestamp":1770453071139,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier","isbn-type":[{"value":"9780128136652","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-813665-2.00010-7","type":"book-chapter","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:43:59Z","timestamp":1520469839000},"page":"375-402","source":"Crossref","is-referenced-by-count":27,"title":["Poly(lactic- co -glycolic acid) (PLGA) matrix implants"],"prefix":"10.1016","author":[{"given":"Joana A.D.","family":"Sequeira","sequence":"first","affiliation":[]},{"given":"Ana C.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Serra","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Ribeiro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pi.1697","article-title":"Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]","volume":"54","author":"Alexis","year":"2005","journal-title":"Polymer Int."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib72","unstructured":"Allergan.com, 2014. Ozurdex \u2013 prescription information. Available from: http:\/\/www.allergan.com\/assets\/pdf\/ozurdex_pi.pdf (accessed 23.10.16)."},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1018932104577","article-title":"Tissue response to bioerodible, subcutaneous drug implants: a possible determinant of drug absorption kinetics","volume":"10","author":"Anderson","year":"1993","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib73","unstructured":"Astrazeneca.com\/media-centre\/press-releases, 2013. AstraZeneca to invest \u00a3120 million in new manufacturing facility to produce Zoladex in Macclesfield. Available from: http:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2013\/astrazeneca-manufacturing-facility-macclesfield-zoladex-prostate-cancer-treatment-11112013.html#! (accessed 10.09.16)."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(96)01544-1","article-title":"In vitro evaluation of Poly(d,l-lactide-co-glycolide) polymer-based implants containing the \u03b1-melanocyte stimulating hormone analog, Melanotan-I","volume":"45","author":"Bhardwaj","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib6","unstructured":"Booth, J., Kittlety, R.S., Gellert, P.R., 2003. Biodegradable implant comprising a polylactide polymer and a lh-rh analogue. Available at: https:\/\/www.google.com\/patents\/WO2003022297A1?cl=es."},{"issue":"6","key":"10.1016\/B978-0-12-813665-2.00010-7_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diab.35.6.692","article-title":"Controlled release of insulin from polymer matrices: control of diabetes in rats","volume":"35","author":"Brown","year":"1986","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/17425247.2.1.29","article-title":"Commercial challenges of protein drug delivery","volume":"2","author":"Brown","year":"2005","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1208\/ps060111","article-title":"Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report","volume":"6","author":"Burgess","year":"2004","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib11","unstructured":"Deghenghi, R., 2000. Implants containing bioactive peptides. Available at: https:\/\/www.google.com\/patents\/US6159490."},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s11095-009-0038-5","article-title":"Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA\/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins","volume":"27","author":"Desai","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5173(02)00431-3","article-title":"Potential applications of PLGA film-implants in modulating in vitro drugs release","volume":"248","author":"Dorta","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib74","unstructured":"EMA.europa.eu, 2015. Ozurdex \u2013 summary of product characteristics (SPC) \u2013 (eMC). Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001140\/WC500095499.pdf (accessed 27.10.16)."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-4804(64)80040-8","article-title":"The use of silicone rubber as a carrier for prolonged drug therapy","volume":"4","author":"Folkman","year":"1964","journal-title":"J. Surg. Res."},{"issue":"1\u20132","key":"10.1016\/B978-0-12-813665-2.00010-7_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/71875","article-title":"Protein stability in controlled-release systems","volume":"18","author":"Fu","year":"2000","journal-title":"Nat Biotech"},{"issue":"2\u20133","key":"10.1016\/B978-0-12-813665-2.00010-7_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0169-409X(97)00036-7","article-title":"Polymeric implants for cancer chemotherapy","volume":"26","author":"Fung","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1\u20133","key":"10.1016\/B978-0-12-813665-2.00010-7_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0168-3659(92)90013-H","article-title":"A biodegradable delivery system for peptides: preclinical experience with the gonadotrophin-releasing hormone agonist Zoladex","volume":"21","author":"Furr","year":"1992","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11095-009-0033-x","article-title":"Improved lysozyme stability and release properties of poly(lactide-co- glycolide) implants prepared by hot-melt extrusion","volume":"27","author":"Ghalanbor","year":"2010","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/B978-0-12-813665-2.00010-7_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2012.09.015","article-title":"Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release","volume":"438","author":"Ghalanbor","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0142-9612(95)93258-F","article-title":"Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence","volume":"16","author":"Grizzi","year":"1995","journal-title":"Biomaterials."},{"issue":"12","key":"10.1016\/B978-0-12-813665-2.00010-7_bib24","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit. Rev. Ther. Drug. Carrier. Syst."},{"issue":"7","key":"10.1016\/B978-0-12-813665-2.00010-7_bib26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jps.21176","article-title":"Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms","volume":"97","author":"Houchin","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejps.2010.05.020","article-title":"Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imaging","volume":"41","author":"H\u00fchn","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/bdd.493","article-title":"Profiling in vitro drug release from subcutaneous implants: a review of current status and potential implications on drug product development","volume":"27","author":"Iyer","year":"2006","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib29","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials."},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib30","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4155\/tde.14.91","article-title":"PLGA: a unique polymer for drug delivery","volume":"6","author":"Kapoor","year":"2015","journal-title":"Therap. Deliv."},{"issue":"11","key":"10.1016\/B978-0-12-813665-2.00010-7_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nmat3758","article-title":"Macroscale delivery systems for molecular and cellular payloads","volume":"12","author":"Kearney","year":"2013","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.02.006","article-title":"Evolution of implantable and insertable drug delivery systems","volume":"181","author":"Kleiner","year":"2014","journal-title":"J. Control. Release"},{"issue":"suppl. 6679","key":"10.1016\/B978-0-12-813665-2.00010-7_bib34","first-page":"5","article-title":"Drug delivery and targeting","volume":"392","author":"Langer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/263797a0","article-title":"Polymers for the sustained release of proteins and other macromolecules","volume":"263","author":"Langer","year":"1976","journal-title":"Nature"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2010.12.020","article-title":"Modeling of drug release from bulk-degrading polymers","volume":"418","author":"Lao","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/B978-0-12-813665-2.00010-7_bib37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/17425240903307431","article-title":"Role of in vitro release models in formulation development and quality control of parenteral depots","volume":"6","author":"Larsen","year":"2009","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/B978-0-12-813665-2.00010-7_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11095-009-0045-6","article-title":"Stability of protein pharmaceuticals: an update","volume":"27","author":"Manning","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib75","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"136","article-title":"Biodegradable polymers as drug carriers","author":"Markland","year":"2002"},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2008.04.004","article-title":"In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting","volume":"129","author":"Martinez","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.09.028","article-title":"Breakout session summary from AAPS\/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products","volume":"142","author":"Martinez","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11095-013-1173-6","article-title":"Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA\/PLGA-PEG blends","volume":"31","author":"Milacic","year":"2014","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/B978-0-12-813665-2.00010-7_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1208\/s12248-010-9175-3","article-title":"Biomaterials\/tissue interactions: possible solutions to overcome foreign body response","volume":"12","author":"Morais","year":"2010","journal-title":"AAPS. J."},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2003.12.008","article-title":"Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies","volume":"95","author":"Negrin","year":"2004","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/B978-0-12-813665-2.00010-7_bib46","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1248\/bpb.28.2011","article-title":"PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases","volume":"28","author":"Onishi","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib47","first-page":"11","article-title":"Foreign body response to subcutaneous implants in diabetic rats","volume":"9","author":"Oviedo Socarr\u00e1s","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P","article-title":"Lymphatic transport of proteins after subcutaneous administration","volume":"89","author":"Porter","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib76","unstructured":"Products.sanofi.ca, 2015. Suprefact depot \u2013 product monography. Available from: http:\/\/products.sanofi.ca\/en\/suprefact-depot.pdf (accessed 12.09.16)."},{"issue":"1\u20133","key":"10.1016\/B978-0-12-813665-2.00010-7_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2007.08.003","article-title":"In vitro and in vivo demonstration of risperidone implants in mice","volume":"98","author":"Rabin","year":"2008","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/B978-0-12-813665-2.00010-7_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0928-0987(97)00022-5","article-title":"Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue","volume":"5","author":"Rothen-Weinhold","year":"1997","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0939-6411(99)00034-X","article-title":"Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants","volume":"48","author":"Rothen-Weinhold","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(98)00376-7","article-title":"Stability studies of a somatostatin analogue in biodegradable implants","volume":"178","author":"Rothen-Weinhold","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0939-6411(00)00066-7","article-title":"Formation of peptide impurities in polyester matrices during implant manufacturing","volume":"49","author":"Rothen-Weinhold","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/B978-0-12-813665-2.00010-7_bib54","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.eurpolymj.2009.07.007","article-title":"hGH release from directly compressed hGH-PLGA biodegradable implantable tablets: Influence of physicomechanical factors","volume":"45","author":"Santove\u00f1a","year":"2009","journal-title":"Eur. Polym J."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2003.09.003","article-title":"In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis","volume":"94","author":"Schliecker","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jconrel.2015.09.052","article-title":"In vitro-in vivo correlation for complex non-oral drug products: where do we stand?","volume":"219","author":"Shen","year":"2015","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpb.2006.06.009","article-title":"Effect of drug type on the degradation rate of PLGA matrices","volume":"64","author":"Siegel","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"Siepmann","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib59","first-page":"409","article-title":"Delivery of peptides and proteins via long acting injections and implants","volume":"2","author":"Stevenson","year":"2012","journal-title":"Adv. Deliv. Sci. Technol."},{"issue":"11","key":"10.1016\/B978-0-12-813665-2.00010-7_bib60","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0142-9612(99)00002-2","article-title":"Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro","volume":"20","author":"Tracy","year":"1999","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/B978-0-12-813665-2.00010-7_bib61","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/cr940351u","article-title":"Polymeric systems for controlled drug release","volume":"99","author":"Uhrich","year":"1999","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2010.10.043","article-title":"Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery","volume":"404","author":"Umeki","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/B978-0-12-813665-2.00010-7_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2015.961420","article-title":"Long-term delivery of protein therapeutics","volume":"12","author":"Vaishya","year":"2015","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"2","key":"10.1016\/B978-0-12-813665-2.00010-7_bib64","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jbm.b.31617","article-title":"A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing process","volume":"93","author":"Wang","year":"2010","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/B978-0-12-813665-2.00010-7_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.11.037","article-title":"The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices","volume":"117","author":"Washington","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jbm.a.30926","article-title":"Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment","volume":"81","author":"Weinberg","year":"2007","journal-title":"J. Biomed. Mater. Res. A."},{"issue":"21","key":"10.1016\/B978-0-12-813665-2.00010-7_bib67","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0142-9612(98)00099-4","article-title":"Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration","volume":"19","author":"Widmer","year":"1998","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/B978-0-12-813665-2.00010-7_bib68","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0142-9612(99)00262-8","article-title":"The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly(lactide-co-glycolide) and ABA triblock copolymers","volume":"21","author":"Witt","year":"2000","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/B978-0-12-813665-2.00010-7_bib70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/1389450115666141122211920","article-title":"Biomedical imaging in implantable drug delivery systems","volume":"16","author":"Zhou","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/B978-0-12-813665-2.00010-7_bib71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/71916","article-title":"Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)","volume":"18","author":"Zhu","year":"2000","journal-title":"Nat. Biotech."}],"container-title":["Nanostructures for the Engineering of Cells, Tissues and Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136652000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136652000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:55:04Z","timestamp":1535032504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128136652000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128136652"],"references-count":74,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813665-2.00010-7","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}